Search Results - techpub+algolia+%3e+vaccines

37 Results Sort By:
MVA and DNA Based SARS-CoV-2 Vaccines
Application Modified Vaccinia virus Ankara (MVA)- and deoxyribonucleic acid (DNA)-based vaccine for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Key Benefits Safety profile is known. Demonstrated antiviral activity against related Coronaviruses. Single dose of vaccination was shown to be effective against related Coronaviruses...
Published: 10/28/2024   |   Inventor(s): Rama Rao Amara, Sailaja Gangadhara
Keywords(s): Biologic, COVID19, Immunology/Inflammation, Microbiology/Infectious Diseases
Category(s): TechPub Algolia > Vaccines
EF-Tu Targeting Antibody for Infection Treatment
Application Therapeutic monoclonal antibodies directed to Elongation Factor-Tu (EF-Tu) for the treatment of infections. Key Benefits An antibody that targets the protein EF-Tu, which is present on many types of bacteria involved in life-threatening infections. A research-grade antibody has been developed with animal data showing the ability to...
Published: 7/30/2024   |   Inventor(s): Joanna Goldberg, Dina Moustafa
Keywords(s): Microbiology/Infectious Diseases, Target, Vaccine
Category(s): TechPub Algolia > Vaccines, TechPub Algolia > Therapeutics
Generation of Vaccines Preventing the Common Cold
Application A new class of vaccines targeting the viruses causing the common cold, rhinoviruses (RV). Key Benefits Capsid-chimeric strains for developing new RV vaccines. Preclinical data with a prototype show the ability to induce a robust capsid-specific immune response. Straightforward and inexpensive vaccine manufacturing process utilizing...
Published: 10/17/2024   |   Inventor(s): Sujin Lee
Keywords(s): Chemistry, Microbiology/Infectious Diseases, Vaccine
Category(s): TechPub Algolia > Vaccines
RSV Vaccine for Infants and Children
Application Vaccine for Respiratory Syncytial Virus (RSV) in infants and children. Key Benefits A novel vaccine targeting both the F and G proteins of the respiratory syncytial virus (RSV), including its variants. Preliminary data in in mice show the vaccine induced the production of antibodies associated with preventing disease. Potential to...
Published: 9/26/2024   |   Inventor(s): Larry Anderson, Binh Ha, Heying Sun
Keywords(s): Microbiology/Infectious Diseases, Pediatrics, Respiratory
Category(s): TechPub Algolia > Vaccines
BG505 SOSIP Vaccine Elicited Neutralizing Monoclonal Antibodies for HIV
­ Application ELISA Western Blot Immunohistochemistry Specficity HIV-1 BG505 Env protein (clone name: YRK01, YRK02). Subtype Monoclonal antibody. Immunogen HIV-1 BG505 SOSIP Env trimer. Technical Summary HIV-1 envelope glycoprotein (Env) is a membrane protein complex involved in receptor recognition and viral fusion with CD4+ T cells...
Published: 10/28/2024   |   Inventor(s): Cynthia Derdeyn, Tysheena Charles
Keywords(s): Antibody, Microbiology/Infectious Diseases
Category(s): TechPub Algolia > Vaccines, TechPub Algolia > Research Tools
Extended Efficacy SARS-COV-2 Vaccine
­ Application A vaccine for SARS-COV-2 that can be used to protect against infection by future forms of Variant-of-Concern (VOC) or other SARS-like coronaviruses. Key Benefits An approach to developing a vaccine that would be effective against future mutations of SARS-COV-2. A vaccine that elicits an immune response to conserved portions...
Published: 10/28/2024   |   Inventor(s): Chinglai Yang, Ling Ye, Samuel Stampfer, Rui Jin
Keywords(s): COVID19
Category(s): TechPub Algolia > Vaccines
HIV-1 Clade C Protein Immunogen as HIV-1 Vaccine
Application Novel stabilized HIV-1 Clade C gp140 trimeric immunogen useful as a vaccine. Key Benefits Vaccine for HIV-1 infections. Induces both neutralizing and V1V2 scaffold directed antibody responses. V1V2 scaffold directed antibodies bind to multiple strains of HIV-1 from different clades including Clades B and C. Market Summary HIV-1...
Published: 10/28/2024   |   Inventor(s): Rama Rao Amara, Sailaja Gangadhara, Tiffany Styles, Anusmita Sahoo
Keywords(s): Immunology/Inflammation, Microbiology/Infectious Diseases
Category(s): TechPub Algolia > Vaccines
Live Attenuated Zika Virus Vaccines
Application Yellow fever virus-based live attenuated Zika virus (ZIKV) vaccines. Key Benefits Reduces neurotropism from Zika virus. High safety and immunogenicity of chimeric vaccines. Market Summary Zika virus (ZIKV) belongs to the flavivirus family of viruses, which include West Nile (WN), Japanese encephalitis (JE), yellow fever (YF), dengue...
Published: 7/30/2024   |   Inventor(s): Baek Kim
Keywords(s): Biologic, Microbiology/Infectious Diseases
Category(s): TechPub Algolia > Vaccines
Boosting Immunogenicity of Vaccines Using Saponins and Agonists of the Intracellular STING Pathway
Application Vaccine formulation of an activator of the stimulator of interferon genes (STING) pathway and saponin adjuvant for enhanced protection of aged population. Key Benefits Significantly improved protective immunity of vaccine in the aged. More efficient than the current methods of influenza vaccination of population 65 years of age or...
Published: 10/28/2024   |   Inventor(s): Elena Vassilieva, Richard Compans
Keywords(s): Immunology/Inflammation, Microbiology/Infectious Diseases, Small Molecule
Category(s): TechPub Algolia > Vaccines
Virus-Like Particles as RSV Vaccine Candidate
Application Virus-like particle (VLP) vaccine candidate(s) to prevent respiratory syncytial virus (RSV) infection. Key Benefits Candidates may have the most effective anti-viral and anti-inflammatory response. Potentially protects elderly and immunocompromised patients from re-infection with the RSV virus. Efficient, tunable and stable production...
Published: 8/22/2024   |   Inventor(s): Binh Ha, Larry Anderson, Elizabeth Wright
Keywords(s): Microbiology/Infectious Diseases, Respiratory
Category(s): TechPub Algolia > Vaccines
1 2 3 4